• 咨询热线
    客服服务热线 13671568941/15317326293
  • 在线咨询
  • 微信客服
    微信客服
  • 公众号
    扫码关注公众号
首页- Products - Apoptosis - Caspase - Taurohyodeoxycholic acid sodium salt

Taurohyodeoxycholic acid sodium salt

CAS No. 110026-03-4

Taurohyodeoxycholic acid sodium salt ( Taurodeoxychloic Acid sodium hydrate | Sodium taurodeoxycholate monohydrate )

产品货号. M21204 CAS No. 110026-03-4

牛磺猪去氧胆酸钠盐是一种亲水性胆盐,对大鼠胆盐和胆汁脂质分泌有影响。

纯度: >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
规格 价格/人民币 库存 数量
5MG ¥503 有现货
100MG 获取报价 有现货
200MG 获取报价 有现货
500MG 获取报价 有现货
1G 获取报价 有现货

生物学信息

  • 产品名称
    Taurohyodeoxycholic acid sodium salt
  • 注意事项
    本公司产品仅用于科研实验,不得用于人体或动物的临床与诊断
  • 产品简述
    牛磺猪去氧胆酸钠盐是一种亲水性胆盐,对大鼠胆盐和胆汁脂质分泌有影响。
  • 产品描述
    Taurohyodeoxycholic acid sodium salt a hydrophilic bile salt on bile salt and biliary lipid secretion in the rat.
  • 体外实验
    Cell Proliferation Assay Cell Line:IEC-6 and caco-2 cells Concentration:0, 0.05, 0.50, and 1.00 mM Incubation Time:1, 2, 4 and 6 days Result:Significantly stimulated intestinal epithelial cell proliferation in a dose-dependent manner. Cell Cycle Analysis Cell Line:IEC-6 cells Concentration:0, 0.05, 0.50, and 1.00 mM Incubation Time:24 hResult:Significantly increased cells in S phase and decreased cells in G1-phase.Western Blot Analysis Cell Line:IEC-6 cells Concentration:0.5 mM Incubation Time:1 and 6 days Result:Significantly increased c-myc protein expression.
  • 体内实验
    Animal Model:C57BL/6N mice, Lipopolysaccharides (HY-D1056) injection model of sepsis Dosage:0.5 mg/kg Administration:Intravenous injection, 30 min or 24 h after LPS injection Result:Improved the survival rate of mice with sepsis. Decreased liver and kidney damage in septic mice. Ameliorated systemic inflammation and normalized blood pressure in septic mice.
  • 同义词
    Taurodeoxychloic Acid sodium hydrate | Sodium taurodeoxycholate monohydrate
  • 通路
    Apoptosis
  • 靶点
    Caspase
  • 受体
    Caspase
  • 研究领域
    ——
  • 适应症
    ——

化学信息

  • CAS Number
    110026-03-4
  • 分子量
    540.71
  • 分子式
    C26H47NNaO7S+
  • 纯度
    >98% (HPLC)
  • 溶解度
    DMSO:125 mg/mL (231.18 mM)
  • SMILES
    C[C@H](CCC(=O)NCCS(=O)(=O)[O-])[C@H]1CC[C@@H]2[C@]1(CC[C@H]3[C@H]2C[C@@H]([C@H]4[C@@]3(CC[C@H](C4)O)C)O)C.[Na+]
  • 化学全称
    ——

运输与储存

  • 储存条件
    (-20℃)
  • 运输条件
    With Ice Pack
  • 稳定性
    ≥ 2 years

参考文献

1.Angelico M Baiocchi L Nistri A et al. Effect of taurohyodeoxycholic acid a hydrophilic bile salt on bile salt and biliary lipid secretion in the rat[J]. Digestive Diseases & Sciences 1994 39(11):2389-2397.
产品手册
关联产品
  • VX-765

    VX-765 (Belnacasan) 是 VRT-043198 的口服吸收前药,VRT-043198 是白细胞介素转换酶/caspase-1 的有效选择性抑制剂,Ki 为 0.8 nM。

  • Linderene

    乌药烯、乌药内酯和异乌药内酯以相同程度抑制两种来源的酶。

  • Z-VAD-FMK

    Z-VAD-FMK 是一种细胞渗透性、不可逆的泛半胱天冬酶抑制剂,可阻断细胞凋亡的所有特征。